Clinical Trial Update: The Study of Atherosclerosis With Ramipril and Rosiglitazone [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ramipril and rosiglitazone for atherosclerosis in individuals with impaired glucose tolerance; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease
• Impaired Glucose Tolerance
• Isolated Impaired Fasting Glucose

Drugs mentioned

• Ramipril (ramipril)
• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Gerstein, Hertzel, MD | Conditions: Atherosclerosis, Impaired Glucose Tolerance | Phase 3 | Status: COMPLETED